This Week in Nature | GenomeWeb

This Week in Nature

In Nature Biotechnology this week, a team led by Massachusetts Institute of Technology researchers report on the use of a gene-editing approach called CRISPR to correct a disease mutation and phenotype in mice, furthering the therapeutic potential of the technology. In the study, the scientists were able to deliver into the animals the Cas9 nuclease, along with a snippet of RNA that directed the enzyme to a specific portion of DNA where it causes double-strand breaks.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.